Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Scholl

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Journal of Breath Research|March 9, 2011
3-Heptanone as a potential new marker for valproic acid therapyS Erhart, A Amann, E Haberlandt, et al.
Cancer Investigation|January 1, 1996
Protracted continuous infusion of 5-fluorouracil in combination with doxorubicin, vincristine, and oral cyclophosphamide in advanced breast cancerE Raymond, T Palangie, M Jouve, et al.
The Journal of Infusional Chemotherapy|January 1, 1996
Ifosfamide seven-day infusion for recurrent and cisplatin refractory ovarian cancerT Dorval, C Soussain, P Beuzeboc, et al.
Genes and Immunity|November 28, 2014
Polymorphisms of Toll-like receptors (TLR2 and TLR4) are associated with the risk of infectious complications in acute myeloid leukemiaU Schnetzke, B Spies-Weisshart, O Yomade, et al.
European Journal of Cancer (Oxford, England : 1990)|November 30, 2000
Predictive factors of response to first-line chemotherapy in 1426 women with metastatic breast cancerM Robain, J Y Pierga, M Jouve, et al.
British Journal of Cancer|July 4, 1998
Randomized trial comparing protracted infusion of 5-fluorouracil with weekly doxorubicin and cyclophosphamide with a monthly bolus FAC regimen in metastatic breast carcinoma (SPM90)J Y Pierga, M Jouve, B Asselain, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Response to chemotherapy is a major parameter-influencing long-term survival of metastatic breast cancer patientsJ Y Pierga, M Robain, M Jouve, et al.
Journal of Inherited Metabolic Disease|April 9, 2008
The relation of cerebrospinal fluid and plasma glycine levels in propionic acidaemia, a 'ketotic hyperglycinaemia'S Scholl-Bürgi, S H Korman, D A Applegarth, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 4, 2014
Clinico-pathology and prognosis of endometrial cancer in patients previously treated for breast cancer, with or without tamoxifen: a comparative study in 363 patientsC Ngô, C Brugier, C Plancher, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 1999
Neoadjuvant chemotherapy in young breast cancer patients: correlation between response and relapse?A C Braud, B Asselain, S Scholl, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Journal of Breath Research|March 9, 2011
3-Heptanone as a potential new marker for valproic acid therapyS Erhart, A Amann, E Haberlandt, et al.
Cancer Investigation|January 1, 1996
Protracted continuous infusion of 5-fluorouracil in combination with doxorubicin, vincristine, and oral cyclophosphamide in advanced breast cancerE Raymond, T Palangie, M Jouve, et al.
The Journal of Infusional Chemotherapy|January 1, 1996
Ifosfamide seven-day infusion for recurrent and cisplatin refractory ovarian cancerT Dorval, C Soussain, P Beuzeboc, et al.
Genes and Immunity|November 28, 2014
Polymorphisms of Toll-like receptors (TLR2 and TLR4) are associated with the risk of infectious complications in acute myeloid leukemiaU Schnetzke, B Spies-Weisshart, O Yomade, et al.
European Journal of Cancer (Oxford, England : 1990)|November 30, 2000
Predictive factors of response to first-line chemotherapy in 1426 women with metastatic breast cancerM Robain, J Y Pierga, M Jouve, et al.
British Journal of Cancer|July 4, 1998
Randomized trial comparing protracted infusion of 5-fluorouracil with weekly doxorubicin and cyclophosphamide with a monthly bolus FAC regimen in metastatic breast carcinoma (SPM90)J Y Pierga, M Jouve, B Asselain, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Response to chemotherapy is a major parameter-influencing long-term survival of metastatic breast cancer patientsJ Y Pierga, M Robain, M Jouve, et al.
Journal of Inherited Metabolic Disease|April 9, 2008
The relation of cerebrospinal fluid and plasma glycine levels in propionic acidaemia, a 'ketotic hyperglycinaemia'S Scholl-Bürgi, S H Korman, D A Applegarth, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 4, 2014
Clinico-pathology and prognosis of endometrial cancer in patients previously treated for breast cancer, with or without tamoxifen: a comparative study in 363 patientsC Ngô, C Brugier, C Plancher, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 1999
Neoadjuvant chemotherapy in young breast cancer patients: correlation between response and relapse?A C Braud, B Asselain, S Scholl, et al.
Pageof 10